| Edit |   |
|---|
| Product Name | GSK J4 |
|---|
| Description | Histone lysine demethylase (KDM) inhibitor; blocks demethylation of histone H3K27. Attenuates lipopolysaccharide (LPS)-induced proinflammatory cytokine production in primary human macrophages (IC50 = 9 μM for the inhibition of TNFα release). Cell permeable. Ethyl ester derivative of GSK J1. Negative Control also available.. Purity 99%. MW (observed): 417.5 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine ethyl ester |
|---|
| Gene, Accession, CAS # | CAS: 1373423-53-0 |
|---|
| Catalog # | 4594/50 |
|---|
| Price | |
|---|
| Order / More Info | GSK J4 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 24276476, 25487152, 25652587, 25671108, 26263556, 26625958, 27010597, 27581455 |
|---|